Modular Medical Secures IRB Approval for Pivot Insulin Pump Study
Modular Medical Inc. has received IRB approval to conduct an in-house study of its Pivot™ insulin delivery system. The study aims to simulate real-world conditions and gather data on device function, usability, and participant feedback. This approval is a key milestone as the company awaits FDA clearance for the Pivot system.
Modular Medical Inc. has received Institutional Review Board (IRB) approval to conduct an in-house study of its next-generation Pivot™ insulin delivery system. The study will deliver insulin to adult participants with diabetes wearing continuous glucose monitors, aiming to simulate real-world conditions and gather data on device function, usability, and participant feedback. This IRB approval is a key milestone as the company awaits FDA clearance for the Pivot system, which has not yet been cleared for sale. No grant or funding from multiple organizations was mentioned. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modular Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1102920) on November 17, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
